en-zh
en-de
en-es
en-fr
en-sl
en
0.25
0.5
0.75
1.25
1.5
1.75
2
Alternative therapies for infectious diseases
Published on 2011-06-064405 Views
This presentation will be about the consequences of inappropriate use of antimicrobial agents and some of the alternative approaches to treating infectious diseases that are being investigated, like n
Related categories
Presentation
Alternative therapies for infectious diseases00:00
Article on antimicrobial resistance02:17
Increasing resistance means02:36
A lack of antibiotics ...03:33
Alternative approaches04:56
Probiotic therapy06:13
How do probiotics work?07:30
Lactobacillus GG09:32
Urogenital tract infections (1)10:53
Urogenital tract infections (2)12:07
Urogenital tract infections (3)12:47
Clostridium difficile13:54
Human gastrointestinal tract14:31
Probiotic treatment of CDI14:57
Effect of LGG yoghurt on Clostridium difficile-associated diarrhoea (1)16:03
Effect of LGG yoghurt on Clostridium difficile-associated diarrhoea (2)16:56
Saccharomyces boulardii18:14
Human studies with S.boulardii18:51
Experiences with S.boulardii (1)20:25
Experiences with S.boulardii (2)21:16
Probiotics for CDI21:27
The ultimate probiotic21:50
Naturally-occurring antimicrobials23:17
Medicinal plants (1)24:06
Medicinal plants (2)24:43
Garlic (Allium sativum) (1)26:15
Garlic (Allium sativum) (2)26:20
Garlic (Allium sativum) (3)28:04
Garlic anti-MRSA activity in vivo28:31
Honey29:20
New Zealand tea tree32:17
Topical honey for diabetic foot ulcers32:37
Qinghaosu (1)33:40
Qinghaosu (2)33:46
The Cranberries34:34
Cranberries (Vaccinium spp.) (1)34:45
Cranberries (Vaccinium spp.) (2)35:33
Teatree road37:31
Australia37:51
Aboriginal remedy38:46
Tea tree oil39:02
Greenhouse with seedlings39:53
Tea tree field40:02
Harvesting (1)40:12
Harvesting (2)40:17
Stump40:20
Distillation40:40
View of distillation shed40:56
Distiller41:05
Tea tree mulch41:11
Tea tree (Melaleuca alternifolia) oil41:23
Components of tea tree oil42:07
Can tea tree (Melaleuca alternifolia) oil prevent MRSA?42:47
MIC/MBC (%) of TTO against skin organisms43:05
Potential for resistance to develop43:33
Formulation issues44:02
In vivo pilot study (1)44:14
In vivo pilot study (2)44:31
Decolonisation study44:34
Presence or absence of MRSA after 14 days45:03
MRSA carriage and clearance at different sites45:21
Germ tube formation45:57
Germ tube formation by C. albicans 10231 in the presence of tea tree oil46:09
Susceptibility of fluconazole susceptible C.albicansto tea tree oil gel47:00
Susceptibility of fluconazole resistant C.albicansto tea tree oil gel47:39
Cold sore pilot study (1)48:11
Cold sore pilot study (2)48:47
Cold sore pilot study results48:51
Other essential oils (1)49:26
Other essential oils (2)49:39
Advantages of phage therapy50:01
Experimental protection of mice51:29
Bacteriophage therapy - issues52:10
Bacteriophage therapy53:10
Anticancer effects53:23
Subcutaneous tumour model53:56
Antitumour effect of 10% TTO/DMSO in s.ctumour models54:24
Why haven´t these treatment options been widely explored further?55:34
Often no obvious protection ...55:44
Conclusions56:10